SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001333277-17-000003
Filing Date
2017-12-04
Accepted
2017-12-04 14:41:28
Documents
1
Period of Report
2017-12-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1546
  Complete submission text file 0001333277-17-000003.txt   3170
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Issuer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address TERRAVIA HOLDINGS, INC. 225 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address (650) 416-5126
Quinlan Paul T (Reporting) CIK: 0001333277 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36500 | Film No.: 171236759